Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12,733,410
-
Total 13F shares
-
4,763,037
-
Share change
-
+43,661
-
Total reported value
-
$140,116,293
-
Price per share
-
$29.41
-
Number of holders
-
58
-
Value change
-
+$1,376,586
-
Number of buys
-
27
-
Number of sells
-
26
Institutional Holders of IRADIMED CORP - Common Stock (IRMD) as of Q2 2021
As of 30 Jun 2021,
IRADIMED CORP - Common Stock (IRMD) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,763,037 shares.
The largest 10 holders included
Nine Ten Capital Management LLC, RENAISSANCE TECHNOLOGIES LLC, Soleus Capital Management, L.P., VANGUARD GROUP INC, BlackRock Inc., Russell Investments Group, Ltd., Ranger Investment Management, L.P., RICE HALL JAMES & ASSOCIATES, LLC, RK Capital Management, LLC, and Mondrian Investment Partners LTD.
This page lists
58
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.